MATTES GLENN R. (President and CEO) sold 83.3% of their position (50K shares) of TFF PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $852.0K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/17/2021ACC: 0001213900-21-016183
DirectorOfficer· President and CEO
Since Oct 2019
-50K
Net shares
Net seller
$852.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
50K acquired · 100K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+50K
Price / share
$2.50
Trade value
$125K
% of position
500.0%
3/15/2021
10K→60K
Common Stock
Direct
Shares
−50K
Price / share
$17.04
Trade value
$852K
% of position
83.3%
3/15/2021
60K→10K
Total
Net shares
+0.00
Net value
-$727K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/15/2021 | M · Option Exercise | +50K | $2.50 | $125K | 500.0% | 10K | 60K |
| Common Stock Direct | 3/15/2021 | S · Sale | −50K | $17.04 | $852K | 83.3% | 60K | 10K |
| Total | +0.00 | -$727K | ||||||
Derivative Transactions1
Stock Options (Right to Buy)
Direct
Converts to
Common Stock
50K shares
Shares
−50K
Strike price
2.5
Held after
944.23K
Exercisable
—
3/15/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) Direct | Common Stock50K shares | 3/15/2021 | M · Option Exercise | −50K | 2.5 | — | 944.23K |